Aaron Richard Kaufman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fuchs' Endothelial Dystrophy | 3 | 2022 | 84 | 1.880 |
Why?
|
Corneal Diseases | 3 | 2023 | 636 | 1.060 |
Why?
|
Glaucoma | 3 | 2023 | 1159 | 0.990 |
Why?
|
Ophthalmology | 2 | 2023 | 508 | 0.930 |
Why?
|
Eye Diseases | 2 | 2023 | 669 | 0.890 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 109 | 0.890 |
Why?
|
Smallpox | 1 | 2023 | 45 | 0.870 |
Why?
|
Keratoconjunctivitis | 1 | 2022 | 53 | 0.850 |
Why?
|
Vaccinia | 1 | 2023 | 76 | 0.850 |
Why?
|
Industrial Oils | 1 | 2022 | 17 | 0.850 |
Why?
|
Acanthamoeba Keratitis | 1 | 2022 | 17 | 0.840 |
Why?
|
Mydriasis | 1 | 2022 | 15 | 0.840 |
Why?
|
Ocular Hypertension | 1 | 2023 | 198 | 0.820 |
Why?
|
Sturge-Weber Syndrome | 1 | 2023 | 91 | 0.810 |
Why?
|
Descemet Membrane | 2 | 2022 | 73 | 0.810 |
Why?
|
Eye Foreign Bodies | 1 | 2022 | 55 | 0.790 |
Why?
|
Blastomycosis | 1 | 2021 | 16 | 0.780 |
Why?
|
Glycopyrrolate | 1 | 2020 | 33 | 0.750 |
Why?
|
Abducens Nerve Diseases | 1 | 2021 | 43 | 0.750 |
Why?
|
Contact Lenses | 1 | 2022 | 145 | 0.750 |
Why?
|
Conjunctiva | 2 | 2021 | 494 | 0.740 |
Why?
|
Hyperhidrosis | 1 | 2020 | 35 | 0.730 |
Why?
|
Plasmacytoma | 1 | 2021 | 183 | 0.730 |
Why?
|
Eye Injuries, Penetrating | 1 | 2022 | 115 | 0.730 |
Why?
|
Purpura | 1 | 2021 | 122 | 0.720 |
Why?
|
Granuloma | 1 | 2022 | 319 | 0.700 |
Why?
|
Eyelid Neoplasms | 1 | 2021 | 94 | 0.690 |
Why?
|
Keratitis | 1 | 2022 | 268 | 0.680 |
Why?
|
Intermittent Claudication | 1 | 2021 | 309 | 0.660 |
Why?
|
Orbit | 1 | 2022 | 426 | 0.650 |
Why?
|
Cornea | 4 | 2022 | 1524 | 0.640 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2018 | 36 | 0.630 |
Why?
|
Neuromyelitis Optica | 1 | 2021 | 252 | 0.600 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 284 | 0.590 |
Why?
|
Herpesvirus 3, Human | 1 | 2018 | 204 | 0.590 |
Why?
|
Artificial Organs | 1 | 2018 | 204 | 0.560 |
Why?
|
Phacoemulsification | 1 | 2017 | 149 | 0.530 |
Why?
|
Lens Implantation, Intraocular | 1 | 2017 | 192 | 0.530 |
Why?
|
Photochemotherapy | 1 | 2022 | 807 | 0.530 |
Why?
|
Optic Nerve Diseases | 1 | 2018 | 327 | 0.490 |
Why?
|
Vision Disorders | 1 | 2021 | 1058 | 0.470 |
Why?
|
Prostheses and Implants | 2 | 2018 | 1387 | 0.470 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 642 | 0.460 |
Why?
|
Conjunctivitis, Allergic | 1 | 2014 | 130 | 0.440 |
Why?
|
Erythema | 1 | 2023 | 257 | 0.400 |
Why?
|
Anisocoria | 2 | 2022 | 10 | 0.400 |
Why?
|
Cholinergic Antagonists | 2 | 2022 | 165 | 0.370 |
Why?
|
Eye | 1 | 2023 | 729 | 0.330 |
Why?
|
Endothelium, Corneal | 2 | 2022 | 199 | 0.320 |
Why?
|
Monkeypox virus | 2 | 2023 | 48 | 0.270 |
Why?
|
Visual Acuity | 3 | 2018 | 2530 | 0.250 |
Why?
|
Multiple Myeloma | 1 | 2021 | 5181 | 0.220 |
Why?
|
Uveitis, Anterior | 1 | 2023 | 101 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9240 | 0.210 |
Why?
|
Corneal Ulcer | 1 | 2023 | 169 | 0.200 |
Why?
|
Sclera | 1 | 2023 | 200 | 0.200 |
Why?
|
Retrospective Studies | 8 | 2023 | 77460 | 0.190 |
Why?
|
Jaw | 1 | 2021 | 96 | 0.190 |
Why?
|
Cranial Fossa, Posterior | 1 | 2021 | 139 | 0.180 |
Why?
|
Humans | 23 | 2023 | 744366 | 0.180 |
Why?
|
Uveitis | 1 | 2023 | 375 | 0.170 |
Why?
|
Eyelids | 1 | 2021 | 265 | 0.160 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2022 | 349 | 0.160 |
Why?
|
Scalp | 1 | 2021 | 380 | 0.160 |
Why?
|
Axilla | 1 | 2020 | 597 | 0.160 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1240 | 0.150 |
Why?
|
Giant Cell Arteritis | 1 | 2021 | 292 | 0.150 |
Why?
|
Intraocular Pressure | 1 | 2023 | 1270 | 0.150 |
Why?
|
Male | 11 | 2023 | 350115 | 0.140 |
Why?
|
Cicatrix | 1 | 2021 | 764 | 0.130 |
Why?
|
Homosexuality, Male | 1 | 2023 | 1240 | 0.130 |
Why?
|
Cesarean Section | 1 | 2023 | 1365 | 0.120 |
Why?
|
Histamine Antagonists | 1 | 2014 | 93 | 0.120 |
Why?
|
Corneal Transplantation | 1 | 2018 | 386 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1771 | 0.110 |
Why?
|
Cataract Extraction | 1 | 2017 | 481 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2023 | 2795 | 0.110 |
Why?
|
Adult | 6 | 2023 | 214052 | 0.100 |
Why?
|
Young Adult | 3 | 2023 | 56429 | 0.100 |
Why?
|
Aged | 5 | 2022 | 163288 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3759 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3486 | 0.090 |
Why?
|
Child | 3 | 2023 | 77709 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8319 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2018 | 2108 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.080 |
Why?
|
Female | 6 | 2023 | 380193 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39052 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4988 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 2987 | 0.070 |
Why?
|
Middle Aged | 4 | 2022 | 213390 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2018 | 15297 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7182 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6234 | 0.060 |
Why?
|
Adolescent | 2 | 2023 | 85779 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.060 |
Why?
|
United States | 3 | 2022 | 69872 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2023 | 25628 | 0.060 |
Why?
|
Isoindoles | 1 | 2022 | 41 | 0.050 |
Why?
|
Trifluridine | 1 | 2022 | 29 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 29060 | 0.050 |
Why?
|
Child, Preschool | 1 | 2023 | 41005 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12961 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 592 | 0.040 |
Why?
|
Benzamides | 1 | 2023 | 1379 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2023 | 63107 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5077 | 0.030 |
Why?
|
Biopsy | 1 | 2023 | 6755 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2023 | 3690 | 0.020 |
Why?
|